Department of Ultrasound, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
Clin Imaging. 2010 Jul-Aug;34(4):288-92. doi: 10.1016/j.clinimag.2010.02.009.
The purpose of the present study is to prepare a nanoscale ultrasound contrast agent and to investigate its characterization and ultrasonic imaging in vivo.
Nanoscale ultrasound contrast agent was prepared by machine vibration and low speed centrifugation, and the appearance, distribution, diameter, and zeta potential of the nanoscale ultrasound contrast agent were measured. Contrast-enhanced ultrasonography was performed on normal rabbit liver to observe the duration and intensity of enhancement.
The nanoscale ultrasound contrast agent had a good shape and uniform distribution by light microscope and transmission electron microscope, with average diameters of 623.4 nm and average zeta potential of 1.3 mV. The contrast imaging study in vivo showed that the nanoscale ultrasound contrast agent could significantly enhance the duration and echo intensity of the vessels and parenchyma in rabbit livers, and there were no obvious difference with micro-scale microbubbles.
The nanoscale ultrasound contrast agent is stable and effective for the enhancement of ultrasound imaging. This study provides an important platform for miniaturizing and improving the targeting performance of ultrasound contrast agents.
本研究旨在制备一种纳米级超声造影剂,并研究其体内的理化特性和超声成像。
通过机械振动和低速离心制备纳米级超声造影剂,测量纳米级超声造影剂的外观、分布、直径和 Zeta 电位。对正常兔肝进行超声造影检查,观察增强的持续时间和强度。
光镜和透射电镜下观察纳米级超声造影剂形态良好,分布均匀,平均粒径为 623.4nm,平均 Zeta 电位为 1.3mV。体内超声造影研究显示,纳米级超声造影剂可明显增强兔肝血管和实质的增强持续时间和回声强度,与微泡相比无明显差异。
纳米级超声造影剂稳定有效,可增强超声成像。本研究为超声造影剂的小型化和靶向性能的改善提供了重要平台。